COVID-19 AESI List 2nd Quarterly Update (December 2020)
SPEAC has completed a second update of the COVID-19 clinical literature covering the period of August 8 through November 13th 2020. Based on this review three entities are being added…
BRIGHTON COLLABORATION NEWS, WEBINARS, PUBLICATIONS AND RELATED TOOLS RELEVANT FOR COVID-19
To view a complete list of BC publications and related tools, please click here. Publications and related tools are organized in a Google spreadsheet that is sortable and filterable by each column. Direct clickable links to publication DOIs are provided.
Tools related to the BC case definition publications are designed to facilitate determining level of diagnostic certainty. Tools may include data abstraction forms, tabular checklists, decision tree algorithms to translate the collected data into a level of diagnostic certainty, and ICD/MedDRA coding.
New BC news, webinars, publications and related tools relevant for COVID-19 will be posted below and added to the spreadsheet as they become available. To view all Brighton Collaboration (BC) news posts, please click here. To view all BC webinar posts, please click here. For translations of BC publications and related tools to languages other than English, please click here.
For all BC resources and tools relevant to COVID-19, please click here.
BC Case Definition: Acute Respiratory Distress Syndrome (ARDS)
This is a The Brighton Collaboration Case Definition of the term “Acute Respiratory Distress Syndrome (ARDS)” to be utilized in the evaluation of adverse events following immunization. The case definition was…
BC Case Definition: Multisystem Inflammatory Syndrome in Children and Adults (MIS-C/A)
This is a Brighton Collaboration Case Definition of the terms "Multisystem Inflammatory Syndrome in Children (MIS-C)" and "Multisystem Inflammatory Syndrome in Adults (MIS-A)" to be utilized in the evaluation of…
Ensuring Safety of COVID-19 Vaccines: Q&A with Robert Chen
Robert Chen, the Scientific Director of Brighton Collaboration, discussed the safety profiles of COVID-19 vaccines with the Coalition for Epidemic Preparedness Innovations (CEPI). To view the article click here.
Addendum to Priority List of Adverse Events of Special Interest: COVID-19
The Coalition for Epidemic Preparedness Innovations (CEPI) has contracted with the Brighton Collaboration, through the Task Force for Global Health (TFGH), to harmonize the safety assessment of CEPI-funded vaccines via its Safety Platform for…
Vaccine-associated Enhanced Disease: Case Definition and Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data
This is a Brighton Collaboration case definition of the term “Vaccine-associated Enhanced Disease” (VAED) to be utilized in the evaluation of adverse events following immunization. The case definition was developed…
Repositories of Publications and Safety Profiles from COVID-19 Vaccine Clinical Trials
To find updated repositories of publications and safety profiles from COVID-19 vaccine clinical trials, please visit one or both of the following external sites: The COVID-19 vaccine tracker from the…
Webinar on Assessment of Vaccine Mediated Enhanced Disease in Epidemiologic Studies Monitoring COVID-19 Vaccines
Vaccine monitoring Collaboration for Europe (VAC4EU) and the Brighton Collaboration's Safety Platform for Emergency vACcines (SPEAC) project jointly held a scientific webinar on how to assess Vaccine Mediated Enhanced Disease…
Webinar on Tools for COVID-19 Vaccine Safety Assessment
Brighton Collaboration's Webinar on Tools for COVID-19 Vaccine Safety Assessment was held on Thursday, August 27th at 11 AM - 12:30 PM EDT | 5 PM - 6:30 PM CEST.For…
Standardized Template for Collection of Key Information for Benefit-Risk Assessment of Inactivated Viral Vaccines
Several inactivated viral vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration (BC) Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO), as part of the Safety Platform for Emergency…
- 1
- 2